Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity

AIM: To evaluate efficacy of intravitreal ranibizumab (IVR) therapy for aggressive posterior retinopathy of prematurity (ROP), threshold ROP disease and type 1 pre-threshold ROP. METHODS: A retrospective analysis was performed on 40 patients (76 eyes) who had IVR as the primary treatment for ROP fro...

Full description

Bibliographic Details
Main Authors: Qiong Zou, Yan-Qiong Zhu, Feng-Jun Zhang, Qiu-Ping Liu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-05-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://ies.ijo.cn/en_publish/2022/5/20220510.pdf